Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT00694707

Femme et Homme

Extrait

This is an study to evaluate the safety, efficacy, and tolerability of RGH-188 relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.


Critère d'inclusion

  • Schizophrenia


Liens